Bacterial Volatiles and Diagnosis of Respiratory Infections

Advances in Applied Microbiology

Volumn 82, Issue , 2013, Pages 29-52

  Graham, James E ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

Bacteria; Breath; VOCs; Volatiles

Indexed keywords

ANTIBIOTIC AGENT; CARBON DIOXIDE; CARBONYL DERIVATIVE; HYDROCARBON; INTERLEUKIN 1BETA; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA; VOLATILE AGENT; VOLATILE ORGANIC COMPOUND; ANTIINFECTIVE AGENT;

ARTICLE; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BURKHOLDERIA CEPACIA; BURKHOLDERIA MULTIVORANS; COMMUNITY ACQUIRED PNEUMONIA; HAEMOPHILUS INFLUENZAE; HUMAN; INFLAMMATION; MORAXELLA CATARRHALIS; MYCOBACTERIUM TUBERCULOSIS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS FLUORESCENS; RESPIRATORY TRACT INFECTION; STREPTOCOCCUS PNEUMONIAE; TUBERCULOSIS; UNITED STATES; BREATH ANALYSIS; CYSTIC FIBROSIS; PSEUDOMONAS INFECTION;

ANTI-BACTERIAL AGENTS; BREATH TESTS; CYSTIC FIBROSIS; HUMANS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; RESPIRATORY TRACT INFECTIONS;

EID: 84873741897     PISSN: 00652164     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-407679-2.00002-8     Document Type: Chapter

References (100)

1. Allardyce R.A., Langford V.S., Hill A.L., Murdoch D.R. Detection of volatile metabolites produced by bacterial growth in blood culture media by selected ion flow tube mass spectrometry (SIFT-MS). Journal of Microbiological Methods 2006, 65:361-365.
2. Bajtarevic A., Ager C., Pienz M., Klieber M., Schwarz K., Ligor M., et al. Noninvasive detection of lung cancer by analysis of exhaled breath. BMC Cancer 2009, 9:348.
3. Baldwin I.T. Plant volatiles. Current Biology 2010, 20:R392-R397.
4. Bartlett J.G. Diagnostic tests for agents of community-acquired pneumonia. Clinical Infectious Diseases 2011, 52(Suppl. 4):S296-S304.
5. Basanta M., Ibrahim B., Douce D., Morris M., Woodcock A., Fowler S.J. Methodology validation, intra-subject reproducibility and stability of exhaled volatile organic compounds. Journal of Breath Research 2012, 6:026002.
6. Bishai W. The Mycobacterium tuberculosis genomic sequence: anatomy of a master adaptor. Trends in Microbiology 1998, 6:464-465.
7. Boots A.W., van Berkel J.J., Dallinga J.W., Smolinska A., Wouters E.F., van Schooten F.J. The versatile use of exhaled volatile organic compounds in human health and disease. Journal of Breath Research 2012, 6:027108.
8. Boshier P.R., Marczin N., Hanna G.B. Repeatability of the measurement of exhaled volatile metabolites using selected ion flow tube mass spectrometry. Journal of the American Society for Mass Spectrometry 2010, 21:1070-1074.
9. Bunge M., Araghipour N., Mikoviny T., Dunkl J., Schnitzhofer R., Hansel A., et al. On-line monitoring of microbial volatile metabolites by proton transfer reaction-mass spectrometry. Applied and Environmental Microbiology 2008, 74:2179-2186.
10. Buszewski B., Kesy M., Ligor T., Amann A. Human exhaled air analytics: biomarkers of diseases. Biomedical Chromatography 2007, 21:553-566.
11. Carey J.R., Suslick K.S., Hulkower K.I., Imlay J.A., Imlay K.R., Ingison C.K., et al. Rapid identification of bacteria with a disposable colorimetric sensing array. Journal of American Chemical Society 2011, 133:7571-7576.
12. Carroll W., Lenney W., Wang T., Spanel P., Alcock A., Smith D. Detection of volatile compounds emitted by Pseudomonas aeruginosa using selected ion flow tube mass spectrometry. Pediatric Pulmonology 2005, 39:452-456.
13. Chambers S.T., Bhandari S., Scott-Thomas A., Syhre M. Novel diagnostics: progress toward a breath test for invasive Aspergillus fumigatus. Medical Mycology 2010, 49(Suppl. 1):S54-S61.
14. Chambers S.T., Syhre M., Murdoch D.R., McCartin F., Epton M.J. Detection of 2-pentylfuran in the breath of patients with Aspergillus fumigatus. Medical Mycology 2009, 47:468-476.
15. Chippendale T.W., Spanel P., Smith D. Time-resolved selected ion flow tube mass spectrometric quantification of the volatile compounds generated by E. coli JM109 cultured in two different media. Rapid Communications in Mass Spectrometry 2011, 25:2163-2172.
16. Costelloe C., Metcalfe C., Lovering A., Mant D., Hay A.D. Effect of antibiotic prescribing in primary care on antimicrobial resistance in individual patients: systematic review and meta-analysis. BMJ 2010, 340:c2096.
17. Delclaux C., Azoulay E. Inflammatory response to infectious pulmonary injury. European Respiratory Journal Supplement 2003, 42:10s-14s.
18. Dunkel M., Schmidt U., Struck S., Berger L., Gruening B., Hossbach J., et al. SuperScent - a database of flavors and scents. Nucleic Acids Research 2009, 37:D291-D294.
19. Eccles R. Understanding the symptoms of the common cold and influenza. Lancet Infectious Diseases 2005, 5:718-725.
20. Effros R.M. Exhaled breath condensate: delusion or dilution?. Chest 2010, 138:471-472.
21. Enderby B., Smith D., Carroll W., Lenney W. Hydrogen cyanide as a biomarker for Pseudomonas aeruginosa in the breath of children with cystic fibrosis. Pediatric Pulmonology 2009, 44:142-147.
22. Fend R., Kolk A.H., Bessant C., Buijtels P., Klatser P.R., Woodman A.C. Prospects for clinical application of electronic-nose technology to early detection of Mycobacterium tuberculosis in culture and sputum. Journal of Clinical Microbiology 2006, 44:2039-2045.
23. Feng X., Siegel M.M. FTICR-MS applications for the structure determination of natural products. Analytical and Bioanalytical Chemistry 2007, 389:1341-1363.
24. File T.M., Solomkin J.S., Cosgrove S.E. Strategies for improving antimicrobial use and the role of antimicrobial stewardship programs. Clinical Infectious Diseases 2011, 53(Suppl. 1):S15-S22.
25. Fine M.J., Smith M.A., Carson C.A., Mutha S.S., Sankey S.S., Weissfeld L.A., et al. Prognosis and outcomes of patients with community-acquired pneumonia. A meta-analysis. JAMA 1996, 275:134-141.
26. Fujitani S., Sun H.Y., Yu V.L., Weingarten J.A. Pneumonia due to Pseudomonas aeruginosa: part I: epidemiology, clinical diagnosis, and source. Chest 2011, 139:909-919.
27. Fu X.A., Li M., Biswas S., Nantz M.H., Higashi R.M. A novel microreactor approach for analysis of ketones and aldehydes in breath. Analyst 2011, 136:4662-4666.
28. Geist H.C.I. Halitosis in ancient literature. Dental Abstracts 1957, 2:417-418.
29. Grosset J. Mycobacterium tuberculosis in the extracellular compartment: an underestimated adversary. Antimicrobial Agents and Chemotherapy 2003, 47:833-836.
30. Guaman A.V., Carreras A., Calvo D., Agudo I., Navajas D., Pardo A., et al. Rapid detection of sepsis in rats through volatile organic compounds in breath. Journal of Chromatography B, Analytical Technologies in the Biomedical and Life Sciences 2012, 881-882:76-82.
31. Hiller N.L., Janto B., Hogg J.S., Boissy R., Yu S., Powell E., et al. Comparative genomic analyses of seventeen Streptococcus pneumoniae strains: insights into the pneumococcal supragenome. Journal of Bacteriology 2007, 189:8186-8195.
32. Horvath I., Hunt J., Barnes P.J., Alving K., Antczak A., Baraldi E., et al. Exhaled breath condensate: methodological recommendations and unresolved questions. European Respiratory Journal 2005, 26:523-548.
33. Hunt J. Condensing exhaled breath into science. Chest 2011, 139:5-6.
34. Ishimaru M., Yamada M., Nakagawa I., Sugano S. Analysis of volatile metabolites from cultured bacteria by gas chromatography/atmospheric pressure chemical ionization-mass spectrometry. Journal of Breath Research 2008, 2:037021.
35. Jassal M.S., Nedeltchev G.G., Lee J.H., Choi S.W., Atudorei V., Sharp Z.D., et al. 13[C]-urea breath test as a novel point-of-care biomarker for tuberculosis treatment and diagnosis. PLoS One 2010, 5:e12451.
36. Johansson N., Kalin M., Tiveljung-Lindell A., Giske C.G., Hedlund J. Etiology of community-acquired pneumonia: increased microbiological yield with new diagnostic methods. Clinical Infectious Diseases 2009, 50:202-209.
37. Junger M., Vautz W., Kuhns M., Hofmann L., Ulbricht S., Baumbach J.I., et al. Ion mobility spectrometry for microbial volatile organic compounds: a new identification tool for human pathogenic bacteria. Applied Microbiology and Biotechnology 2012, 93:2603-2614.
38. Kai M., Haustein M., Molina F., Petri A., Scholz B., Piechulla B. Bacterial volatiles and their action potential. Applied Microbiology and Biotechnology 2009, 81:1001-1012.
39. Kesselmeir A., Staudt M. Biogenic volatile organic compounds (VOC): an overview on emission, physiology, and ecology. Journal of Atmospheric Sciences 1999, 33:23-88.
40. King J., Koc H., Unterkofler K., Mochalski P., Kupferthaler A., Teschl G., et al. Physiological modeling of isoprene dynamics in exhaled breath. Journal of Theoretical Biology 2010, 267:626-637.
41. King J., Unterkofler K., Teschl G., Teschl S., Koc H., Hinterhuber H., et al. A mathematical model for breath gas analysis of volatile organic compounds with special emphasis on acetone. Journal of Mathematical Biology 2011, 63:959-999.
42. Kolk A.H., van Berkel J.J., Claassens M.M., Walters E., Kuijper S., Dallinga J.W., et al. Breath analysis as a potential diagnostic tool for tuberculosis. International Journal of Tuberculosis and Lung Diseases 2012, 16:777-782.
43. Kwak J., Preti G. Volatile disease biomarkers in breath: a critique. Current Pharmaceutical Biotechnology 2011, 12:1067-1074.
44. Laaks J., Jochmann M.A., Schmidt T.C. Solvent-free microextraction techniques in gas chromatography. Analytical and Bioanalytical Chemistry 2011, 402:565-571.
45. Labows J.N., McGinley K.J., Webster G.F., Leyden J.J. Headspace analysis of volatile metabolites of Pseudomonas aeruginosa and related species by gas chromatography-mass spectrometry. Journal of Clinical Microbiology 1980, 12:521-526.
46. Lai S.Y., Deffenderfer O.F., Hanson W., Phillips M.P., Thaler E.R. Identification of upper respiratory bacterial pathogens with the electronic nose. Laryngoscope 2002, 112:975-979.
47. Lechner M., Karlseder A., Niederseer D., Lirk P., Neher A., Rieder J., et al. H. pylori infection increases levels of exhaled nitrate. Helicobacter 2005, 10:385-390.
48. Li M., Biswas S., Nantz M.H., Higashi R.M., Fu X.A. Preconcentration and analysis of trace volatile carbonyl compounds. Analytical Chemistry 2011, 84:1288-1293.
49. Lim W.S., Macfarlane J.T., Boswell T.C., Harrison T.G., Rose D., Leinonen M., et al. Study of community-acquired pneumonia aetiology (SCAPA) in adults admitted to hospital: implications for management guidelines. Thorax 2001, 56:296-301.
50. Mann F.M., Xu M., Chen X., Fulton D.B., Russell D.G., Peters R.J. Edaxadiene: a new bioactive diterpene from Mycobacterium tuberculosis. Journal of American Chemical Society 2009, 131:17526-17527.
51. Mashir A., Paschke K.M., van Duin D., Shrestha N.K., Laskowski D., Storer M.K., et al. Effect of the influenza A (H1N1) live attenuated intranasal vaccine on nitric oxide (FE(NO)) and other volatiles in exhaled breath. Journal of Breath Research 2011, 5:037107.
52. Mgode G.F., Weetjens B.J., Cox C., Jubitana M., Machang'u R.S., Lazar D., et al. Ability of Cricetomys rats to detect Mycobacterium tuberculosis and discriminate it from other microorganisms. Tuberculosis (Edinburgh) 2011, 92:182-186.
53. Mgode G.F., Weetjens B.J., Nawrath T., Cox C., Jubitana M., Machang'u R.S., et al. Diagnosis of tuberculosis by trained African giant pouched rats and confounding impact of pathogens and microflora of the respiratory tract. Journal of Clinical Microbiology 2011, 50:274-280.
54. Miekisch W., Schubert J.K., Noeldge-Schomburg G.F. Diagnostic potential of breath analysis - focus on volatile organic compounds. Clinica Chimica Acta 2004, 347:25-39.
55. Montuschi P. Analysis of exhaled breath condensate in respiratory medicine: methodological aspects and potential clinical applications. Therapeutic Advances in Respiratory Diseases 2007, 1:5-23.
56. Nawrath T., Mgode G.F., Weetjens B., Kaufmann S.H., Schulz S. The volatiles of pathogenic and nonpathogenic mycobacteria and related bacteria. Beilstein Journal of Organic Chemistry 2012, 8:290-299.
57. Neuhauser M.M., Weinstein R.A., Rydman R., Danziger L.H., Karam G., Quinn J.P. Antibiotic resistance among gram-negative bacilli in US intensive care units: implications for fluoroquinolone use. JAMA 2003, 289:885-888.
58. O'Hara M., Mayhew C.A. A preliminary comparison of volatile organic compounds in the headspace of cultures of Staphylococcus aureus grown in nutrient, dextrose and brain heart bovine broths measured using a proton transfer reaction mass spectrometer. Journal of Breath Research 2009, 3:027001.
59. Pathak C.M., Bhasin D.K., Khanduja K.L. Urea breath test for Helicobacter pylori detection: present status. Tropical Gastroenterology 2004, 25:156-161.
60. Pauling L., Robinson A.B., Teranishi R., Cary P. Quantitative analysis of urine vapor and breath by gas-liquid partition chromatography. Proceedings of the National Academy of Sciences of the United States of America 1971, 68:2374-2376.
61. Phillips M. Method for the collection and assay of volatile organic compounds in breath. Analytical Biochemistry 1997, 247:272-278.
62. Phillips M., Basa-Dalay V., Blais J., Bothamley G., Chaturvedi A., Modi K.D., et al. Point-of-care breath test for biomarkers of active pulmonary tuberculosis. Tuberculosis (Edinburgh) 2012, 92:314-320.
63. Phillips M., Basa-Dalay V., Bothamley G., Cataneo R.N., Lam P.K., Natividad M.P., et al. Breath biomarkers of active pulmonary tuberculosis. Tuberculosis (Edinburgh) 2010, 90:145-151.
64. Phillips M., Cataneo R.N., Condos R., Ring Erickson G.A., Greenberg J., La Bombardi V., et al. Volatile biomarkers of pulmonary tuberculosis in the breath. Tuberculosis (Edinburgh) 2007, 87:44-52.
65. Phillips M., Greenberg J. Ion-trap detection of volatile organic compounds in alveolar breath. Clinical Chemistry 1992, 38:60-65.
66. Phillips M., Greenberg J., Awad J. Metabolic and environmental origins of volatile organic compounds in breath. Journal of Clinical Pathology 1994, 47:1052-1053.
67. Prach L., Kirby J., Keasling J.D., Alber T. Diterpene production in Mycobacterium tuberculosis. FEBS Journal 2010, 277:3588-3595.
68. Preti G., Thaler E., Hanson C.W., Troy M., Eades J., Gelperin A. Volatile compounds characteristic of sinus-related bacteria and infected sinus mucus: analysis by solid-phase microextraction and gas chromatography-mass spectrometry. Journal of Chromatography B, Analytical Technologies in the Biomedical and Life Sciences 2009, 877:2011-2018.
69. Purkhart R., Kohler H., Liebler-Tenorio E., Meyer M., Becher G., Kikowatz A., et al. Chronic intestinal Mycobacteria infection: discrimination via VOC analysis in exhaled breath and headspace of feces using differential ion mobility spectrometry. Journal of Breath Research 2011, 5:027103.
70. Ramirez J.A., Anzueto A.R. Changing needs of community-acquired pneumonia. Journal of Antimicrobial Chemotherapy 2011, 66(Suppl. 3):iii3-iii9.
71. Robroeks C.M., van Berkel J.J., Dallinga J.W., Jobsis Q., Zimmermann L.J., Hendriks H.J., et al. Metabolomics of volatile organic compounds in cystic fibrosis patients and controls. Pediatric Research 2010, 68:75-80.
72. Rosias P. Methodological aspects of exhaled breath condensate collection and analysis. Journal of Breath Research 2012, 6:027102.
73. Rosias P., Robroeks C., Hendriks J., Dompeling E., Jobsis Q. Exhaled breath condensate: a space odessey, where no one has gone before. European Respiratory Journal 2004, 24:189-190. author reply 190.
74. Saad R.J., Chey W.D. Breath tests for gastrointestinal disease: the real deal or just a lot of hot air?. Gastroenterology 2007, 133:1763-1766.
75. Savelev S.U., Perry J.D., Bourke S.J., Jary H., Taylor R., Fisher A.J., et al. Volatile biomarkers of Pseudomonas aeruginosa in cystic fibrosis and noncystic fibrosis bronchiectasis. Letters in Applied Microbiology 2011, 52:610-613.
76. Schulz S., Dickschat J.S. Bacterial volatiles: the smell of small organisms. Natural Product Reports 2007, 24:814-842.
77. Scott-Thomas A., Pearson J., Chambers S. Potential sources of 2-aminoacetophenone to confound the Pseudomonas aeruginosa breath test, including analysis of a food challenge study. Journal of Breath Research 2011, 5:046002.
78. Scott-Thomas A.J., Syhre M., Pattemore P.K., Epton M., Laing R., Pearson J., et al. 2-Aminoacetophenone as a potential breath biomarker for Pseudomonas aeruginosa in the cystic fibrosis lung. BMC Pulmonary Medicine 2010, 10:56.
79. Scotter J.M., Allardyce R.A., Langford V.S., Hill A., Murdoch D.R. The rapid evaluation of bacterial growth in blood cultures by selected ion flow tube-mass spectrometry (SIFT-MS) and comparison with the BacT/ALERT automated blood culture system. Journal of Microbiological Methods 2006, 65:628-631.
80. Shestivska V., Nemec A., Drevinek P., Sovova K., Dryahina K., Spanel P. Quantification of methyl thiocyanate in the headspace of Pseudomonas aeruginosa cultures and in the breath of cystic fibrosis patients by selected ion flow tube mass spectrometry. Rapid Communications in Mass Spectrometry 2011, 25:2459-2467.
81. Skogerson K., Wohlgemuth G., Barupal D.K., Fiehn O. The volatile compound BinBase mass spectral database. BMC Bioinformatics 2011, 12:321.
82. Smith T. Breath analysis: clinical research to the end-user market. Journal of Breath Research 2011, 5:032001.
83. Spanel P., Smith D. Comment on 'influences of mixed expiratory sampling parameters on exhaled volatile organic compound concentrations'. Journal of Breath Research 2011, 5:048001.
84. Strand N., Bhushan A., Schivo M., Kenyon N.J., Davis C.E. Chemically polymerized polypyrrole for on-chip concentration of volatile breath metabolites. Sensors and Actuators B: Chemical 2010, 143:516-523.
85. Suckling D.M., Sagar R.L. Honeybees Apis mellifera can detect the scent of Mycobacterium tuberculosis. Tuberculosis (Edinburgh) 2011, 91:327-328.
86. Syhre M., Chambers S.T. The scent of Mycobacterium tuberculosis. Tuberculosis (Edinburgh) 2008, 88:317-323.
87. Syhre M., Manning L., Phuanukoonnon S., Harino P., Chambers S.T. The scent of Mycobacterium tuberculosis - part II breath. Tuberculosis (Edinburgh) 2009, 89:263-266.
88. Teranishi R., Mon T.R., Robinson A.B., Cary P., Pauling L. Gas chromatography of volatiles from breath and urine. Analytical Chemistry 1972, 44:18-20.
89. Thekedar B., Oeh U., Szymczak W., Hoeschen C., Paretzke H.G. Influences of mixed expiratory sampling parameters on exhaled volatile organic compound concentrations. Journal of Breath Research 2011, 5:016001.
90. Thorn R.M., Greenman J. Microbial volatile compounds in health and disease conditions. Journal of Breath Research 2012, 6:024001.
91. Thorn R.M., Reynolds D.M., Greenman J. Multivariate analysis of bacterial volatile compound profiles for discrimination between selected species and strains in vitro. Journal of Microbiological Methods 2010, 84:258-264.
92. Tonkin-Crine S., Yardley L., Little P. Antibiotic prescribing for acute respiratory tract infections in primary care: a systematic review and meta-ethnography. Journal of Antimicrobial Chemotherapy 2011, 66:2215-2223.
93. Trivedi A., Singh N., Bhat S.A., Gupta P., Kumar A. Redox biology of tuberculosis pathogenesis. Advances in Microbial Physiology 2012, 60:263-324.
94. Ustianowski A. Diagnostics for community-acquired and atypical pneumonia. Current Opinion in Pulmonary Medicine 2012, 18:259-263.
95. Weetjens B.J., Mgode G.F., Machang'u R.S., Kazwala R., Mfinanga G., Lwilla F., et al. African pouched rats for the detection of pulmonary tuberculosis in sputum samples. International Journal of Tuberculosis and Lung Diseases 2009, 13:737-743.
96. Whittle C.L., Fakharzadeh S., Eades J., Preti G. Human breath odors and their use in diagnosis. Annals of the New York Academy of Sciences 2007, 1098:252-266.
97. WHO, 2010. Global Tuberculosis Control.
98. Woolfenden E. Sorbent-based sampling methods for volatile and semi-volatile organic compounds in air. Part 2. Sorbent selection and other aspects of optimizing air monitoring methods. Journal of Chromatography A 2010, 1217:2685-2694.
99. Zechman J.M., Aldinger S., Labows J.N. Characterization of pathogenic bacteria by automated headspace concentration-gas chromatography. Journal of Chromatography 1986, 377:49-57.
100. Zhang J., Fang A., Wang B., Kim S.H., Bogdanov B., Zhou Z., et al. iMatch: a retention index tool for analysis of gas chromatography-mass spectrometry data. Journal of Chromatography A 2011, 1218:6522-6530.